Literature DB >> 33567897

Sirt5 Deficiency Causes Posttranslational Protein Malonylation and Dysregulated Cellular Metabolism in Chondrocytes Under Obesity Conditions.

Shouan Zhu1, Albert Batushansky1, Anita Jopkiewicz1,2, Dawid Makosa1, Kenneth M Humphries1,3,4, Holly Van Remmen1,2,3,5, Timothy M Griffin1,2,3,4,5.   

Abstract

OBJECTIVE: Obesity accelerates the development of osteoarthritis (OA) during aging and is associated with altered chondrocyte cellular metabolism. Protein lysine malonylation (MaK) is a posttranslational modification (PTM) that has been shown to play an important role during aging and obesity. The objective of this study was to investigate the role of sirtuin 5 (Sirt5) in regulating MaK and cellular metabolism in chondrocytes under obesity-related conditions.
METHODS: MaK and SIRT5 were immunostained in knee articular cartilage of obese db/db mice and different aged C57BL6 mice with or without destabilization of the medial meniscus surgery to induce OA. Primary chondrocytes were isolated from 7-day-old WT and Sirt5-/- mice and treated with varying concentrations of glucose and insulin to mimic obesity. Sirt5-dependent effects on MaK and metabolism were evaluated by western blot, Seahorse Respirometry, and gas/chromatography-mass/spectrometry (GC-MS) metabolic profiling.
RESULTS: MaK was significantly increased in cartilage of db/db mice and in chondrocytes treated with high concentrations of glucose and insulin (GluhiInshi). Sirt5 was increased in an age-dependent manner following joint injury, and Sirt5 deficient primary chondrocytes had increased MaK, decreased glycolysis rate, and reduced basal mitochondrial respiration. GC-MS identified 41 metabolites. Sirt5 deficiency altered 13 distinct metabolites under basal conditions and 18 metabolites under GluhiInshi treatment. Pathway analysis identified a wide range of Sirt5-dependent altered metabolic pathways that include amino acid metabolism, TCA cycle, and glycolysis.
CONCLUSION: This study provides the first evidence that Sirt5 broadly regulates chondrocyte metabolism. We observed changes in SIRT5 and MaK levels in cartilage with obesity and joint injury, suggesting that the Sirt5-MaK pathway may contribute to altered chondrocyte metabolism that occurs during OA development.

Entities:  

Keywords:  chondrocyte; lysine malonylation; metabolism; osteoarthritis; sirtuin 5

Mesh:

Substances:

Year:  2021        PMID: 33567897      PMCID: PMC8804736          DOI: 10.1177/1947603521993209

Source DB:  PubMed          Journal:  Cartilage        ISSN: 1947-6035            Impact factor:   3.117


  41 in total

1.  Mitochondrial biogenesis is impaired in osteoarthritis chondrocytes but reversible via peroxisome proliferator-activated receptor γ coactivator 1α.

Authors:  Yun Wang; Xianling Zhao; Martin Lotz; Robert Terkeltaub; Ru Liu-Bryan
Journal:  Arthritis Rheumatol       Date:  2015-05       Impact factor: 10.995

2.  Knee osteoarthritis has doubled in prevalence since the mid-20th century.

Authors:  Ian J Wallace; Steven Worthington; David T Felson; Robert D Jurmain; Kimberly T Wren; Heli Maijanen; Robert J Woods; Daniel E Lieberman
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-14       Impact factor: 11.205

Review 3.  The role of mitochondria in osteoarthritis.

Authors:  Francisco J Blanco; Ignacio Rego; Cristina Ruiz-Romero
Journal:  Nat Rev Rheumatol       Date:  2011-01-04       Impact factor: 20.543

Review 4.  The Mitochondrial Acylome Emerges: Proteomics, Regulation by Sirtuins, and Metabolic and Disease Implications.

Authors:  Chris Carrico; Jesse G Meyer; Wenjuan He; Brad W Gibson; Eric Verdin
Journal:  Cell Metab       Date:  2018-03-06       Impact factor: 27.287

5.  SIRT5 Regulates both Cytosolic and Mitochondrial Protein Malonylation with Glycolysis as a Major Target.

Authors:  Yuya Nishida; Matthew J Rardin; Chris Carrico; Wenjuan He; Alexandria K Sahu; Philipp Gut; Rami Najjar; Mark Fitch; Marc Hellerstein; Bradford W Gibson; Eric Verdin
Journal:  Mol Cell       Date:  2015-06-11       Impact factor: 17.970

6.  Lysine malonylation is elevated in type 2 diabetic mouse models and enriched in metabolic associated proteins.

Authors:  Yipeng Du; Tanxi Cai; Tingting Li; Peng Xue; Bo Zhou; Xiaolong He; Peng Wei; Pingsheng Liu; Fuquan Yang; Taotao Wei
Journal:  Mol Cell Proteomics       Date:  2014-11-23       Impact factor: 5.911

Review 7.  Emerging role of metabolic signaling in synovial joint remodeling and osteoarthritis.

Authors:  Ronald K June; Ru Liu-Bryan; Fanxing Long; Timothy M Griffin
Journal:  J Orthop Res       Date:  2016-09-26       Impact factor: 3.494

Review 8.  The global burden of other musculoskeletal disorders: estimates from the Global Burden of Disease 2010 study.

Authors:  Emma Smith; Damian G Hoy; Marita Cross; Theo Vos; Mohsen Naghavi; Rachelle Buchbinder; Anthony D Woolf; Lyn March
Journal:  Ann Rheum Dis       Date:  2014-03-03       Impact factor: 19.103

Review 9.  Functions of the sirtuin deacylase SIRT5 in normal physiology and pathobiology.

Authors:  Surinder Kumar; David B Lombard
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04-11       Impact factor: 8.250

10.  Sirtuin5 contributes to colorectal carcinogenesis by enhancing glutaminolysis in a deglutarylation-dependent manner.

Authors:  Yun-Qian Wang; Hao-Lian Wang; Jie Xu; Juan Tan; Lin-Na Fu; Ji-Lin Wang; Tian-Hui Zou; Dan-Feng Sun; Qin-Yan Gao; Ying-Xuan Chen; Jing-Yuan Fang
Journal:  Nat Commun       Date:  2018-02-07       Impact factor: 14.919

View more
  3 in total

Review 1.  Fundamentals of OA. An initiative of Osteoarthritis and Cartilage. Obesity and metabolic factors in OA.

Authors:  A Batushansky; S Zhu; R K Komaravolu; S South; P Mehta-D'souza; T M Griffin
Journal:  Osteoarthritis Cartilage       Date:  2021-09-17       Impact factor: 6.576

2.  The Metabolic Landscape in Osteoarthritis.

Authors:  Xiaoxin Wu; Xiwei Fan; Ross Crawford; Yin Xiao; Indira Prasadam
Journal:  Aging Dis       Date:  2022-07-11       Impact factor: 9.968

Review 3.  Oncometabolites drive tumorigenesis by enhancing protein acylation: from chromosomal remodelling to nonhistone modification.

Authors:  Yidian Fu; Jie Yu; Fang Li; Shengfang Ge
Journal:  J Exp Clin Cancer Res       Date:  2022-04-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.